Just a listing for easy reference;
RECRUITING: Dose-escalation, Dose-expansion Study of Safety of PBCAR0191 in Patients With r/r NHL and r/r B-cell ALL
https://www.clinicaltrials.gov/study/NCT03666000
RECRUITING: A Study of onCARlytics (CF33-CD19) in Combination With Blinatumomab in Adults With Advanced or Metastatic Solid Tumors (OASIS) (OASIS)
https://www.clinicaltrials.gov/study/NCT06063317
RECRUITING: A Study of CF33-hNIS (VAXINIA), an Oncolytic Virus, as Monotherapy or in Combination With Pembrolizumab in Adults With Metastatic or Advanced Solid Tumors (MAST)
https://www.clinicaltrials.gov/study/NCT05346484
ACTIVE, NOT RECRUITING: Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON) (nextHERIZON)
https://www.clinicaltrials.gov/study/NCT05311176
ACTIVE, NOT RECRUITING: A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults With Non-Small Cell Lung Cancer
https://www.clinicaltrials.gov/study/NCT04432207
ACTIVE, NOT RECRUITING:A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer
https://www.clinicaltrials.gov/study/NCT02795988
ACTIVE, NOT RECRUITING: CF33-hNIS-antiPDL1 for the Treatment of Metastatic Triple Negative Breast Cancer
https://www.clinicaltrials.gov/study/NCT05081492
All Clinical trial links
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.6¢ |
Change
0.001(0.91%) |
Mkt cap ! $402.5M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.6¢ | 5.5¢ | $407.7K | 7.376M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 25 | 831513 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.6¢ | 1338725 | 12 |
View Market Depth
| Last trade - 11.14am 25/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |